EDWARD KAZMIR: Open Payments
NPI 1336641208 · ROSENBERG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 5 payments from 4 companies in 2025. Trend: 2023 $1,203 · 2024 $344 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 2 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $102 |
| E.R. Squibb & Sons, L.L.C. | 1 | $97 |
Products named: CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, COBENFY.
Industry payments across TX — which companies pay providers there.
